PTI Launches Game-Based Learning for the Pharma, Biotech and Medical Device Industries
Pharmaceutical Training International (PTI), the leading supplier of online and public, event-based training courses for the pharma, biotech and medical device sectors, has launched a range of game-based e-learning courses. PTI’s unique game-based modules offer new interactive approaches using both 2D and 3D interactive environments. Users will benefit from a more engaging, entertaining and cost-saving method of acquiring new skills through role-play in real world scenarios. To mark the launch, PTI is running a competition until the 26 March which provides access to the new platform and a chance to win a free e-learning course or a 50% discount on a PTI public, event-based training course.
PTI is the first company to bring the innovative game-based interactive approach to training in the (bio)pharma and medical device sectors, enhancing its existing range of popular e-Learning courses. Including topics in business strategy, clinical, manufacturing, medical devices and diagnostics, R&D and regulatory affairs, a range of modules have now been created to allow ‘players’ to learn through interactive quizzes and a 3D virtual environment. Already used successfully in other sectors, the game-based learning approach enhances traditional training methods for personnel in the (bio)pharma and medical device industries, promoting friendly competition and providing motivation for staff to become more efficient, productive and knowledgeable.
Speaking about this new approach, PTI’s Managing Director, Rosie Bernard said: “At PTI, we want to bring the very best learning experience to our customers, whether they are looking for distance learning, event based or tailored on-site training. Game-based learning is a new approach for our customers that will help them develop new skills in a much more engaging and entertaining way.”
Competition entrants can experience and explore the 3D interactive environment while competing with colleagues around the globe by selecting their area of interest and completing an interactive quiz. The competition closes on Thursday 26 March and winners will be selected on Friday 27 March 2015.
For UK start-ups and SMEs, PTI is able to offer a special discount on training courses on an ongoing basis as a Cogent-accredited training partner for the Science Industry Partnership (SIP) skills for growth programme.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance